-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Neutral on Conmed, Lowers Price Target to $52

Benzinga·12/08/2025 13:11:40
语音播报
B of A Securities analyst Travis Steed maintains Conmed (NYSE:CNMD) with a Neutral and lowers the price target from $65 to $52.